secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
CIK:        0000315545
Form:       8-K
Filed at:   2025-04-16T23:59:59+00:00
Accession:  0001641172-25-004995
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Provectus BioPharma appoints CBIZ as new auditor following Marcum acquisition
-----------------------------------------------------------------------------

- Marcum LLP resigned as independent auditor on April 15, 2025, due to its acquisition by CBIZ.
- Audit Committee approved engagement of CBIZ CPAs P.C. as successor auditor on the same date.
- No disagreements or reportable events occurred with Marcum during 2024, 2023, or through resignation date.
- Audit reports for fiscal years 2024 and 2023 were unmodified and not qualified.
- Marcum letter agreeing with statements filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/315545/000164117225004995/0001641172-25-004995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/315545/000164117225004995/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-004995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer